» Authors » Sinem Civriz Bozdag

Sinem Civriz Bozdag

Explore the profile of Sinem Civriz Bozdag including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 188
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan T, Bulbul M, Kaysin M, Dogan I, Akay O, Bozdag S
Turk J Haematol . 2025 Feb; PMID: 39960211
No abstract available.
2.
Tan T, Seymen H, Bozdag S, Akay O, Topcu A
J Cancer Res Clin Oncol . 2025 Feb; 151(2):85. PMID: 39948307
No abstract available.
3.
Tan T, Bozdag S
Blood Res . 2024 Dec; 59(1):39. PMID: 39621189
Understanding the intricacies of the pathophysiology and genomic landscape has enhanced the long-term outcomes for patients with acute myeloid leukemia (AML). The identification of novel molecular targets has introduced new...
4.
Mehtap O, Toptas T, Dal M, Keklik Karadag F, Atas U, Ozsan G, et al.
Leuk Lymphoma . 2024 Sep; 65(14):2190-2198. PMID: 39269267
Predictive prognostic scoring (PS) systems are not primarily applicable to elderly patients with classical Hodgkin lymphoma (cHL). The objective of this study was to develop a PS system for these...
5.
Noyan S, Gundogdu F, Bozdag S
Support Care Cancer . 2023 Mar; 31(4):244. PMID: 36977784
Purpose: This study investigated the incidence of fatigue, insomnia, depression, anxiety, and stress symptoms in patients after allogeneic hematopoietic stem cell transplantation (AHSCT), as well as explored potential relationships among...
6.
Seval G, Bozdag S, Toprak S, Kurt Yuksel M, Topcuoglu P, Arslan O, et al.
Balkan Med J . 2023 Mar; 40(3):197-204. PMID: 36959692
Background: Allogeneic hematopoietic stem cell transplantation is a well-established approach for patients diagnosed with primary myelofibrosis and remains the only potentially curative treatment. Aims: To present the overall outcome of...
7.
Kircali E, Seval G, Ozturk C, Yilmaz H, Koyun D, Bozdag S, et al.
Balkan Med J . 2022 Dec; 40(1):51-56. PMID: 36571427
Background: Eltrombopag has an off-label indication for haematopoietic cell transplantation in patients experiencing delayed thrombocyte recovery and/or thrombocytopaenia. Aims: To present our centre’s experience of using this agent not only...
8.
Cebeci C, Gerede Uludag D, Tan T, Koyuncu I, Bozdag S, Dincer I, et al.
Kardiol Pol . 2022 Jul; 80(7-8):853-856. PMID: 35819990
No abstract available.
9.
Koyun D, Seval G, Kircali E, Bozdag S, Toprak S, Topcuoglu P, et al.
Indian J Hematol Blood Transfus . 2022 Jun; 38(3):601-605. PMID: 35747565
Steroid-refractory acute graft-versus-host disease (SR-aGVHD) treatment has a low response rate and a high risk of infection in allogeneic hematopoietic stem cell transplantation. The standard approach to be applied in...
10.
Kahilogullari G, Bayatli E, Geyik M, Cabuk B, Beton S, Gunaldi O, et al.
Br J Neurosurg . 2022 May; 37(2):206-212. PMID: 35582922
Purpose: Sellar metastases are rare lesions. Recent improvements in diagnosis and treatment strategies have prolonged survival but increased the probability of metastatic tumors. Evaluation with clinical symptomatology and meticulous laboratory...